Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Scientific Reports|April 2, 2021
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumabLucía Trilla-Fuertes, Angelo Gámez-Pozo, Joan Maurel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 2015
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) studyYolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela, et al.
The Oncologist|April 25, 2020
Predicting Chemotherapy Toxicity in Older Patients with Cancer: A Multicenter Prospective StudyJaime Feliu, Beatriz Jiménez-Munárriz, Laura Basterretxea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2011
A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancerEnrique Casado, Victor Moreno García, Jose Javier Sánchez, et al.
The Lancet. Oncology|June 4, 2024
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 studyJean-Luc Van Laethem, Ivan Borbath, Hans Prenen, et al.
The Oncologist|March 28, 2025
Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospitalAntonio Rueda-Lara, David Viñal, Daniel Martínez-Pérez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 TrialBruno Bockorny, Teresa Macarulla, Valerya Semenisty, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Cancers|February 25, 2022
Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?Jorge Luis Ramon-Patino, Ignacio Ruz-Caracuel, Victoria Heredia-Soto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR TrialFrancesca Sarno, Jair Tenorio, Sofia Perea, et al.
Pageof 13